Overview
The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.
Description
This study is a non-randomized, prospective, open-label registry to compare the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stents versus other drug-eluting stents (DES) in patients with coronary artery disease.
Eligibility
Inclusion Criteria:
- Patients ≥ 19 years old
- Patients receiving Synergy XD stent(s) or Synergy Megatron™ stent(s).
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria:
- Patients with a mixture of other drug-eluting stents (DESs)
- Terminal illness with life-expectancy ≤1 year.
- Patients with cardiogenic shock